Sign up for free insights newsletter
CB

Clinica Baviera

CBAVBolsa de Madrid

Need professional-grade analysis? Visit stockanalysis.com

€49.20
-0.81%
End of day
Market Cap

$816.73M

P/E Ratio

19.77

Employees

1,847

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-2.240.981.782.521.761.42
Calmar-8.551.853.133.460.991.22
Sharpe-1.530.631.121.621.000.86
Omega0.671.141.231.301.251.18
Martin-13.893.806.958.222.523.43
Ulcer3.515.254.865.5613.877.34

Clinica Baviera (CBAV) Price Performance

Clinica Baviera (CBAV) trades on Bolsa de Madrid in EUR. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at EUR49.20, down 0.81% from the previous close.

Over the past year, CBAV has traded between a low of EUR31.54 and a high of EUR55.60. The stock has gained 41.2% over this period. It is currently 11.5% below its 52-week high.

Clinica Baviera has a market capitalization of $816.73M, with a price-to-earnings ratio of 19.77.

About Clinica Baviera

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics in Spain and Europe. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, farsightedness, presbyopia, cataract, retinal, plastic surgery, pediatric ophthalmology, glaucoma, strabismus, cornea, neuro-ophthalmology, tear ducts, oculoplasty, lasik, and intraocular lenses treatments. The company was formerly known as Clínica Oftalmológica Baviera, S.L. and changed its name to Clínica Baviera, S.A. in 2000. Clínica Baviera, S.A. was incorporated in 1992 and is headquartered in Madrid, Spain. Clínica Baviera, S.A. is a subsidiary of Aier Eye International (Europe), S.L.U.

Company Info

Exchange
Bolsa de Madrid
Currency
EUR
Country
Spain

Financial Metrics

Revenue (TTM)
$304.91M
EBITDA
$84.54M
Profit Margin
13.80%
EPS (TTM)
2.58
Book Value
6.87

Technical Indicators

52 Week High
€56.60
52 Week Low
€28.82
50 Day MA
€51.77
200 Day MA
€45.55
Beta
0.68

Valuation

Trailing P/E
19.77
Forward P/E
41.84
Price/Sales
2.68
Price/Book
7.43
Enterprise Value
$774.24M